Gemzar (Bladder Cancer) - Analysis and Forecasts to 2020


#28413

21pages

GlobalData

$ 2000

In Stock

 

GlobalDatas pharmaceuticals report, Gemzar (Bladder Cancer) Analysis and Forecasts to 2020 provides Gemzar global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Bladder Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

 

Scope

 

  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
  • Analysis and review of Gemzar including sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Gemzar including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Global sales forecast for 2002-2020 for Gemzar

 

Reasons to buy

 

  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

 

Table of content

1 Table of contents 2
1.1 List of Tables 2
1.2 List of Figures 2

2 Introduction 4
2.1 Bladder Cancer Market 4
2.2 Bladder Cancer Disease 4
2.3 GlobalData Pipeline Report Guidance 7

3 Baldder Cancer Disease: Market Characterization 8
3.1 Bladder Cancer Disease Market 8
3.2 Bladder Cancer Disease Market Forecasts and CAGR 8
3.3 Drivers for the Bladder Cancer Disease Market 8
3.3.1 High Prevalence 9
3.3.2 High Incidence 9
3.3.3 High Survival Rate 10
3.3.4 High lifetime costs 10

4 TNM Classification of bladder cancer 11
4.1 American Urological Association 11

5 Gemzar 14
5.1 Introduction 14
5.2 Mechanism of Action 14
5.3 Clinical Studies 14
5.4 Approval History of Gemzar 15
5.5 Gold Standard Treatment 15
5.6 Sales drivers 15
5.6.1 Bladder Cancer Market 15
5.6.2 MVAC Toxicity Profile 16
5.6.3 Large Unmet need 16
5.7 Drug Risk Benefit Score 16
5.7.1 Efficacy 16
5.7.2 Safety 16
5.7.3 Compliance 17
5.7.4 Dosing Convenience 17
5.8 Sales forecast 17
5.8.1 Target patient Pool of Gemzar 17
5.8.2 Dosing 18
5.8.3 Market Penetration 18
5.8.4 Annual Cost of Therapy 18
5.8.5 Sales Projections of Gemzar 18

6 Bladder Cancer Market: Appendix 19
6.1 Market Definitions 19
6.2 List of Abberiviations 19
6.3 Research Methodology 19
6.3.1 Coverage 19
6.3.2 Secondary Research 19
6.3.3 Forecasting 20
6.3.4 Number of Patients Approved to take the Drug 20
6.3.5 Net Penetration of Drug 20
6.3.6 Net Annual Dosing 20
6.3.7 Annual Cost of Therapy 21
6.3.8 Primary Research 21
6.3.9 Expert Panels 21
6.4 Contact Us 21
6.5 Disclaimer 21
6.6 Sources 21

 


Table 1: Bladder Cancer Incidences & Mortality 5
Table 2: Bladder Cancer, Global, Market Forecast ($bn), 20022020 8
Table 3: Approval History of Gemzar 15
Table 4: Annual Cost of Therapy 18


Figure 1: Percentage Distribution of Top 20 Diagnosed Cancers 4
Figure 2: Fatality = [(%Distribution of Incidence) (% Distribution Mortality )] of Top 20 Cancers 5
Figure 3: Percentage share of risk factors in Developed Countries 6
Figure 4: Percentage share of risk factors in Developing Countries 6
Figure 5: Smoking Consumption Curve, US 6
Figure 6: Forecasted Global Bladder Cancer Market 8
Figure 7: All Cancer Incidence Worldwide 9
Figure 8: Bladder Cancer Incidence Worldwide 9
Figure 9: Broad Classification of Bladder Cancer 11
Figure 10: Classification of NMI Bladder Cancer 11
Figure 11: Detailed TNM Classifications 12
Figure 12: Classification of NMI Bladder Cancer 13